Improvement of fibrosis in a patient with chronic myeloproliferative disease.
Retter
Andrew
A
Department of Haematology, Guy's and St Thomas NHS Foundation Trust, London, UK. retter.andrew@gstt.nhs.uk
Radia
Deepti H
DH
Harrison
Claire N
CN
D000328:Adult; D001706:Biopsy; D005500:Follow-Up Studies; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D019384:Nucleic Acid Synthesis Inhibitors / Q000627:therapeutic use; D011087:Polycythemia Vera / Q000150:complications* / Q000188:drug therapy; D055728:Primary Myelofibrosis / Q000209:etiology* / Q000473:pathology
D016898:Interferon-alpha; D019384:Nucleic Acid Synthesis Inhibitors; D006918:Hydroxyurea